XML 77 R45.htm IDEA: XBRL DOCUMENT
v3.21.2

Revenues and Trade Receivables, Net, Concentration of Major Customers (Details) - Customer Concentration Risk | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020
Revenue | Indivior |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk | 68.00% | 48.00% |
Revenue | Sunovion Pharmaceuticals, Inc |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk |  | 39.00% |
Receivables | Indivior |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk | 68.00% |  | 53.00%
Receivables | AmerisourceBergen |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk | 10.00% |  | 14.00%
Receivables | Sunovion Pharmaceuticals, Inc |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk |  |  | 13.00%
Receivables | Cardinal |  |  |
Customer Concentration [Abstract] |  |  |
Concentrations of risk |  |  | 10.00%

X
- References No definition available. + Details
Name: | aqst_CustomerConcentrationAbstract
Namespace Prefix: | aqst_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=aqst_CommercialExploitationAgreementWithIndiviorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=aqst_SunovionPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=aqst_AmerisourceBergenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=aqst_CardinalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |